#USA #Austin #PrimeVigilance #Oracle Argus #Ergomed Group

PrimeVigilance Leverages Oracle Argus for Enhanced Patient Safety and Efficiency

In a significant leap towards enhancing its service offerings, PrimeVigilance, a renowned Contract Research Organization (CRO), has adopted the Oracle Argus platform. This strategic move aims to bolster the efficiency and accuracy of drug development processes while prioritizing patient safety and adhering to regulatory guidelines. The collaboration showcases PrimeVigilance's commitment to providing robust pharmacovigilance solutions powered by artificial intelligence (AI).

Sally Amanuel, President of PrimeVigilance, articulated the need for improved safety strategies, citing the rapid influx of data from emerging sources coupled with evolving regulations. She stated, "Changing regulations and the rapid increase of data from new sources demand improved safety strategies." By harnessing the capabilities of Oracle Argus, PrimeVigilance can now enhance safety monitoring protocols, streamline operations, and allow their teams to focus on critical activities that improve patient outcomes.

Oracle Argus stands out as the industry leader in pharmacovigilance safety solutions, processing a staggering 10 million adverse event cases annually. This platform sets the benchmark for the efficient processing, analysis, and reporting of safety data during clinical trials, thereby enabling companies to maintain high standards of patient safety.

Recently, PrimeVigilance also joined Oracle's Lighthouse development program, aimed at faster pharmacovigilance innovation. By integrating insights from the CRO's experience, the collaboration intends to bolster pharmacovigilance excellence throughout the life sciences sector, enhancing operational efficiency, regulatory adherence, and patient safety insights.

Seema Verma, Executive Vice President and General Manager at Oracle Health and Life Sciences, remarked, "Oracle Argus has been the gold standard in pharmacovigilance for decades. Working with organizations like PrimeVigilance, we are building on that excellence to deliver cloud-based, AI-enabled solutions that improve safety monitoring for the benefit of the industry and the patients waiting for potentially lifesaving solutions."

About PrimeVigilance

A prominent member of the Ergomed Group, PrimeVigilance specializes in pharmacovigilance, offering global solutions for clinical safety and post-marketing surveillance. With operational hubs strategically located in Europe, the U.S., India, and Japan, PrimeVigilance boasts a wealth of experience in delivering high-quality, cost-effective safety solutions tailored to the needs of over 200 clients worldwide.

Their flexible and customized approach ensures that their pharmacovigilance solutions align seamlessly with clients' clinical and post-marketing requirements, creating a comprehensive global pharmacovigilance system that supports safe product distribution across international markets. For more information, visit www.primevigilance.com.

About Oracle Life Sciences

Oracle Life Sciences is at the forefront of cloud technology and pharmaceutical research, trusted globally by both large and emerging companies in the clinical research and pharmacovigilance domains. With over two decades of experience, Oracle Life Sciences focuses on supporting clinical development and leveraging real-world evidence to drive innovation and progress in the life sciences industry, ultimately enhancing patient outcomes. To learn more, visit www.oracle.com/lifesciences.

Conclusion

The adoption of Oracle Argus by PrimeVigilance marks a pivotal development in the realm of pharmacovigilance. By streamlining operations and leveraging state-of-the-art technology, PrimeVigilance is set to play a crucial role in enhancing patient safety and regulatory compliance, ensuring that drug development processes are not only more efficient but also more reliable in safeguarding public health.